NSPR250117P5000
- 0.00
- 0.000.00%
InspireMD Newsroom
Express News | InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $5
InspireMD Says Shore Will Remain as CFO Until His Successor Is Appointed >NSPR
Press Release: InspireMD Announces Expected Retirement of Its CFO Craig Shore and CFO Transition in 2025
InspireMD Initiated at Buy by Lake Street
InspireMD Price Target Announced at $5.00/Share by Lake Street
InspireMD Analyst Ratings
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study
Lake Street Initiates InspireMD(NSPR.US) With Buy Rating, Announces Target Price $5
InspireMD Begins Pivotal Study of CGuard Prime in TCAR Procedures
InspireMD Announces First Patient Enrolled in CGUARDIANS II Study
Express News | InspireMD Announces First Patient Enrolled in the Cguardians II Pivotal Study of the Cguard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (Tcar)
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)
Express News | CORRECTION: InspireMD Q1Numbers Are Old And Were Published Erroneously; Now Deleted
InspireMD Q1 EPS $(6.45) Beats $(9.45) Estimate, Sales $1.03M Beat $1.00M Estimate
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press Release: InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors
Express News | InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors